Wegovy Weight Loss Injection is a once-weekly prescription treatment designed for chronic weight management
Many patients notice appetite suppression and improved energy within the first few weeks
Who is Most Likely to Be Affected and What to Watch For People with diabetes, uncontrolled or fluctuating blood sugar, a history of recurrent yeast infections, recent antibiotic use, or significant rapid weight loss may face higher odds of a yeast episode while on semaglutide
This allows for a gradual, customized pace that aims to achieve weight loss goals while minimizing side effects
Severe effects requiring immediate emergency care include severe abdominal pain, yellowing of skin or eyes, swelling of the face or throat, difficulty breathing, fainting, vision changes, or very rapid heartbeat
The generic debut comes after Novo Nordisk, in 2019, failed to pay a $250 CAD maintenance fee on Canadian patent CA 2601784